Clinical trial
Mazdutide for Remission of Type 2 Diabetes: Multicentre, Double Blind, Randomised, Placebo Controlled Trial
NCT07767552 is registered in ClinicalTrials.gov with Yanbing Li as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mazdutide for Remission of Type 2 Diabetes: Multicentre, Double Blind, Randomised, Placebo Controlled Trial
- Lead sponsor
- Yanbing Li
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- June 30, 2029
- Enrollment
- 249 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.